We are live on ! Find out more
NFG

Noven Financial Group Portfolio holdings

AUM $123M
1-Year Est. Return 5.23%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+5.23%
3 Year Est. Return
+45.07%
5 Year Est. Return
+66.39%
10 Year Est. Return
AUM
$145M
AUM Growth
Cap. Flow
+$144M
Cap. Flow %
99.12%
Top 10 Hldgs %
81.75%
Holding
30
New
29
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 18.43%
2 Technology 0.8%
3 Financials 0.3%
4 Communication Services 0.21%
5 Real Estate 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.51T
$309K 0.21%
+5,660
New +$284K
WPC icon
27
W.P. Carey
WPC
$17B
$308K 0.21%
+5,131
New +$323K
VHC icon
28
VirnetX Holding Corp
VHC
$51M
$235K 0.16%
+606
New +$241K
PSTV icon
29
Plus Therapeutics
PSTV
$25.7M
0
MUX icon
30
McEwen Inc
MUX
$1.04B
$21K 0.01%
+1,050
New +$21.4K

Similar funds

Noven Financial Group's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Noven Financial Group, which disclosed 30 positions worth $145M. Its ten largest holdings account for 82% of the portfolio.

Its largest position is Ampio Pharmaceuticals Inc.: 12,450 shares worth $26.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, followed by Technology and Financials.

  • Noven Financial Group's largest Q4 2013 buy was Ampio Pharmaceuticals Inc.: 12,450 shares worth $26.6M.
  • Noven Financial Group's ten largest holdings make up 82% of its $145M portfolio in Q4 2013.
  • Noven Financial Group disclosed 30 positions in Q4 2013, its first 13F filing on record.

Based on Noven Financial Group's 13F filing for Q4 2013, filed 4 Feb 2014.